Therapeutic Asset Ratings
230 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Egl-001
Solid Tumor, Adult
Egle Therapeutics
P1/2
CC
(41)
FLUDEOXYGLUCOSE
Solid Tumor, Adult
Rahul Aggarwal
P1/2
CC
(41)
Fmc-376
Solid Tumor, Adult
Frontier Medicines Corporation
P1/2
CC
(41)
gad20-209-fsp, rp2d
Solid Tumor, Adult
Nouscom SRL
P1/2
CC
(41)
Gad-209-Fsp High Dose
Solid Tumor, Adult
Nouscom SRL
P1/2
CC
(41)
Garsorasib
Solid Tumor, Adult
InventisBio Co., Ltd
P1/2
CC
(41)
gw786034
Solid Tumor, Adult
Tianjin Medical University Second Hospital
P1/2
CC
(41)
hb0045 drug product
Solid Tumor, Adult
Shanghai Huaota Biopharmaceutical Co., Ltd.
P1/2
CC
(41)
Hst-1011
Solid Tumor, Adult
HotSpot Therapeutics, Inc
P1/2
CC
(41)
Hydroxychloroquine
Solid Tumor, Adult
Medical University of South Carolina
P1/2
CC
(41)
ima402
Solid Tumor, Adult
Immatics Biotechnologies GmbH
P1/2
CC
(41)
kb707
Solid Tumor, Adult
Krystal Biotech, Inc.
P1/2
CC
(41)
lns8801
Solid Tumor, Adult
Linnaeus Therapeutics, Inc.
P1/2
CC
(41)
Mdna11
Solid Tumor, Adult
Medicenna Therapeutics, Inc.
P1/2
CC
(41)
Mva-209-Fsp, Rp2D
Solid Tumor, Adult
Nouscom SRL
P1/2
CC
(41)
Nelfinavir
Solid Tumor, Adult
Medical University of South Carolina
P1/2
CC
(41)
OMBURTAMAB
Solid Tumor, Adult
Y-mAbs Therapeutics
P1/2
CC
(41)
Rapamycin
Solid Tumor, Adult
Medical University of South Carolina
P1/2
CC
(41)
Solnerstotug
Solid Tumor, Adult
Sensei Biotherapeutics, Inc.
P1/2
CC
(41)
Tixestobart
Solid Tumor, Adult
Genmab
P1/2
CC
(41)
Toripalimab
Solid Tumor, Adult
Suzhou Abogen Biosciences Co., Ltd.
P1/2
CC
(41)
Tyra-300
Solid Tumor, Adult
Tyra Biosciences, Inc
P1/2
CC
(41)
Vesanoid
Solid Tumor, Adult
Gustave Roussy, Cancer Campus, Grand Paris
P1/2
CC
(41)
Visugromab
Solid Tumor, Adult
CatalYm GmbH
P1/2
CC
(41)
vs-7375
Solid Tumor, Adult
Verastem, Inc.
P1/2
CC
(41)
Showing 76 to 100 of 230 assets
Previous
Page 4 of 10
Next
